AI-Driven Peptide Discovery: How Machine Learning Is Redesigning the Drug Pipeline
From generative models designing antimicrobial peptides in hours to the first AI-designed peptide entering human clinical trials, artificial intelligence is fundamentally reshaping how peptide therapeutics are discovered, optimized, and brought to patients.